Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer

Author：                              

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.2, 2014-01, pp. : 212-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 60-65

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum-based agents for individualized Cancer Treatmen

By  

Current Molecular Medicine, Vol. 13, Iss. 10, 2013-12 ,pp. : 1603-1612

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of chemotherapy plus gefitinib treatment in advanced nonsmallcell lung cancer patients following acquired resistance to gefitinib

By    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

By  

Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. : 175-178

Bentham Science Publishers

Access to resources Recommend Favorite

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer†

By  

Current Molecular Medicine, Vol. 16, Iss. 3, 2016-03 ,pp. : 222-231

Bentham Science Publishers

Access to resources Recommend Favorite